Understanding the influence of individual variables contributing to multivariate outliers in assessments of data quality
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - September 27, 2018 Category: Statistics Authors: Richard C. Zink,
Laura Castro ‐Schilo,
Jianfeng Ding Source Type: research
Issue Information
Pharmaceutical Statistics,Volume 17, Issue 5, Page 397-399, September/October 2018. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - September 19, 2018 Category: Statistics Source Type: research
Application of Bayesian analyses to doubly randomized delayed start, matched control designs to demonstrate disease modification
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - September 17, 2018 Category: Statistics Authors: IbrahimTurkoz
,
MarcSobel
,
LarryAlphs Source Type: research
A case study of an adaptive design for a clinical trial with 2 doses and 2 endpoints in a rare disease area
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - September 17, 2018 Category: Statistics Authors: HuiQuan
,
YiXu
,
YixinChen
,
LeiGao
,
XunChen Source Type: research
A practical guide to pre ‐trial simulations for Bayesian adaptive trials using SAS and BUGS
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - September 14, 2018 Category: Statistics Authors: Christian HolmHansen
,
PamelaWarner
,
AllanWalker
,
Richard A.Parker
,
LucyWhitaker
,
Hilary O.D.Critchley
,
Christopher J.Weir Source Type: research
Bayesian detection of potential risk using inference on blinded safety data
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 31, 2018 Category: Statistics Authors: SaurabhMukhopadhyay
,
BrianWaterhouse
,
AlanHartford Source Type: research
Reasonable two ‐stage adaptive designs for single‐arm phase II clinical trials
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 31, 2018 Category: Statistics Authors: KosukeKashiwabara
,
YutakaMatsuyama Source Type: research
Nonparametric response ‐adaptive randomization for continuous responses
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 28, 2018 Category: Statistics Authors: ZhongqiangLiu
,
FeifangHu
,
Li ‐XinZhang Source Type: research
Phase 3 adaptive trial design options in treatment of complicated urinary tract infection
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 28, 2018 Category: Statistics Authors: KertViele
,
Linda M.Mundy
,
Robert B.Noble
,
GangLi
,
KristineBroglio
,
Jeffrey D.Wetherington Source Type: research
Exact and asymptotic tests under the sequential parallel comparison design
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 24, 2018 Category: Statistics Authors: Kung ‐JongLui Source Type: research
Effect of a statistical outlier in potency bioassays
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 16, 2018 Category: Statistics Authors: PercevalSondag
,
LingminZeng
,
BinbingYu
,
R éjaneRousseau
,
BrunoBoulanger
,
HarryYang
,
StevenNovick Source Type: research
Single arm two ‐stage studies: Improved designs for molecularly targeted agents
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 16, 2018 Category: Statistics Authors: P.Dutton
,
J.Holmes Source Type: research
Subgroup ‐specific dose finding in phase I clinical trials based on time to toxicity allowing adaptive subgroup combination
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 16, 2018 Category: Statistics Authors: Andrew G.Chapple
,
Peter F.Thall Source Type: research
A Bayesian hierarchal modeling approach to shortening phase I/II trials of anticancer drug combinations
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 16, 2018 Category: Statistics Authors: ShinjoYada
,
ChikumaHamada Source Type: research
Bayesian dose ‐finding phase I trial design incorporating pharmacokinetic assessment in the field of oncology
Pharmaceutical Statistics, EarlyView. (Source: Pharmaceutical Statistics)
Source: Pharmaceutical Statistics - August 1, 2018 Category: Statistics Authors: KentaroTakeda
,
KanjiKomatsu
,
SatoshiMorita Source Type: research
